Documents to download

In 2015, the Government committed 5 years of extra funding for Children and Young People’s Mental Health Services (CYPMHS). All areas of England were required to submit plans outlining how they will improve their services by 2020. This POSTnote describes some of the new models of CYPMHS and examines the challenges to their effective implementation.

Acknowledgements
POSTnotes are based on literature reviews and interviews with
a range of stakeholders and are externally peer reviewed.
POST would like to thank interviewees and peer reviewers
for kindly giving up their time during the preparation of this briefing
including:
Polly Ashmore, NHS England
Nigel Atter, British Psychological Society
Andy Bell, Centre for Mental Health
Elaine Bousfield, Xenzone
Dr Marc Bush, YoungMinds
Sinem Cakir, MAC-UK
Emily Frith, Education Policy Institute
Professor Peter Fonagy, UCL, Anna Freud National Centre
for Children and Families.
James Kenrick, Youth Access
Paula Lavis, Children and Young People’s Mental Health Coalition
David Lockwood, NHS England
Emma Louisy, Tavistock and Portman NHS Foundation
Anna Moore, Tavistock and Portman NHS Foundation
Lisa Nolan, Liverpool CCG
Fiona Pienaar, Place2Be
Tom Powell, House of Commons Library
Kathryn Pugh, NHS England

Documents to download

Related posts

  • AI and healthcare

    There are various applications of Artificial Intelligence (AI) in healthcare, such as helping clinicians to make decisions, monitoring patient health, and automating routine administrative tasks. This POSTnote gives an overview of these uses, and their potential impacts on the cost and quality of healthcare, and on the workforce. It summarises the challenges to wider adoption of AI in healthcare, including those relating to safety, privacy, data-sharing, trust, accountability and health inequalities. It also outlines some of the regulations relevant to AI, and how these may change. As healthcare is a devolved issue, policies on healthcare AI differ across the UK. This POSTnote focusses on regulations and policies relevant to England.

  • Manufacturing COVID-19 vaccines

    The rapid production of safe, effective and consistent vaccines is essential for supporting COVID-19 immunisation programmes in the UK and globally. However, manufacturing vaccines is challenging for various reasons that include the complex processes involved, the specialist knowledge and experience required, and the natural variability of the biological materials and systems used. Urgent demand is leading to manufacturers and governments taking on significant financial risks in order to speed up production. What is the UK Government doing to accelerate vaccine manufacture? How are vaccines made? Why is manufacturing vaccines at large scales so challenging?

  • COVID-19 and the digital divide

    The digital divide is the gap between people in society who have full access to digital technologies (such as the internet and computers) and those who do not. Concerns about the digital divide have been particularly acute during the COVID-19 pandemic as the internet and digital devices have played an important role in allowing people to access services, attend medical appointments and stay in touch with friends and family. What impact has the digital divide had on children and adults in the UK during the COVID-19 pandemic and what has been done to tackle it?